Global Assets Advisory LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 59.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,140 shares of the healthcare conglomerate’s stock after selling 1,689 shares during the quarter. Global Assets Advisory LLC’s holdings in UnitedHealth Group were worth $575,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the fourth quarter worth about $30,000. Finally, AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on UNH. Robert W. Baird reduced their price target on UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. KeyCorp lowered their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Truist Financial dropped their price target on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a research report on Monday, April 21st. Finally, Royal Bank of Canada lowered their price objective on UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $596.86.
UnitedHealth Group Stock Down 1.3 %
UNH stock opened at $380.72 on Friday. The business’s 50-day moving average is $488.01 and its two-hundred day moving average is $522.60. The company has a market cap of $346.54 billion, a price-to-earnings ratio of 24.56, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a fifty-two week low of $378.54 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the firm posted $6.91 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 35.18%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Stock Dividend Cuts Happen Are You Ready?
- Google Is Betting Big on Nuclear Reactors—Should You?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.